Results 41 to 50 of about 111,297 (312)
Frontiers in PediatricsBackgroundPropranolol for infantile hemangiomas (IHs) is effective and relatively safe. However, propranolol has different formulations and there is no consensus on the optimal formulation for IHs.
Wenting Chen +8 more
doaj +1 more source
Toxics, 2022 Severe hyper-catecholaminergic states likely cause heart failure and cardiac fibrosis. While previous studies demonstrated the effects of beta-blockade in experimental models of single-catecholamine excess states, the detailed benefits of beta-blockade ...
Cheng-Ken Tsai +6 more
doaj +1 more source
, 1978 Effects of propranolol on ischemic segmental function were studied in anesthetized open-chest dogs. Two segment-length gauges were used for measuring the regional myocardial function: one was sutured on to the left ventricular surface perfused by the ...
Yoshida, Hidenori +7 more
core +1 more source
Propranolol in Treatment of Huge and Complicated Infantile Hemangiomas in Egyptian Children
Dermatology Research and Practice, 2014 Background. Infantile hemangiomas (IHs) are the most common benign tumours of infancy. Propranolol has recently been reported to be a highly effective treatment for IHs.
Basheir A. Hassan, Khalid S. Shreef
doaj +1 more source
Trigeminovascular effects of propranolol in men and women, role for sex steroids
Annals of Clinical and Translational Neurology, 2022 Objective Assess whether propranolol modulates the trigeminovascular system in both men and women. Methods We investigated the effect of propranolol (80 mg, 90 min after oral administration, corresponding to Tmax) on the increase in dermal blood flow of ...
Eloísa Rubio‐Beltrán +10 more
doaj +1 more source
Evaluating the Safety of Oral Propranolol Therapy in Patients With PHACE Syndrome.
JAMA dermatology, 2019 Importance Oral propranolol is widely considered to be first-line therapy for complicated infantile hemangioma, but its use in patients with PHACE (posterior fossa malformations, hemangioma, arterial anomalies, cardiac defects, eye anomalies) syndrome ...
G. Olsen +24 more
semanticscholar +1 more source
Propranolol for small abdominal aortic aneurysms: Results of a randomized trial
, 2002 Purpose: Animal and human studies have suggested that beta-blockade may decrease the growth rate of aneurysms. We investigated whether propranolol decreases the growth rate of small abdominal aortic aneurysms (AAAs).
The Propranolol Aneurysm Trial Investigators,
core +1 more source
Deep coma in a child treated with propranolol for infantile hemangioma
BMC Pediatrics, 2019 Background Propranolol hydrochloride is the first-line agent recommended for the treatment of infantile hemangiomas (IH). Serious adverse effects of propranolol therapy for hemangiomas are infrequent.
Ilirjana Bakalli +7 more
doaj +1 more source
Propranolol exhibits activity against hemangiomas independent of beta blockade
npj Precision Oncology, 2019 Propranolol is a widely used beta blocker that consists of a racemic mixture of R and S stereoisomers. Only the S stereoisomer has significant activity against the beta-adrenergic receptor.
Maiko Sasaki +11 more
semanticscholar +1 more source
Propranolol in hypertension [PDF]
Postgraduate Medical Journal, 1968 Summary Twenty-four hypertensive patients, eleven of whom had angina pectoris as well, have been treated with propranolol in doses up to 400 mg daily. The thirteen patients without angina received methyldopa 2 g daily in addition to propranolol. A significant reduction of systolic and diastolic blood pressure was found in both groups.
S N, Tewari, R H, Grant
openaire +2 more sources